HDAC9 and cancer: As another example, SIN3A is part of the SIN3A-HDAC complex that is associated with diseases including cancer [47], and HDAC inhibitors are known to potentiate CDDP activity [48–50], thus providing moderate but indirect evidence in favor of the reported pair SIN3A-HDAC.